Global Ocular Disorders Overview - Rising Therapeutics, Technologies, and Devices - 200 Companies & 250 Clinical Trials - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Ocular Disorders: Rising Therapeutics, Technologies, and Devices - Overview " report to their offering.

Available to Report is Ocular Disorders: Rising Therapeutics, Technologies, and Devices Report. This report begins with outlining Age-related macular degeneration (both wet and dry) and delving into Anti-VEGF therapies in chapter 2. Further providing substantial weight to this report, several companies were interviewed on their approach to targeting wet and dry AMD, their strategies for seeking alternative therapeutic options, and the hardships they have encountered in their research and product execution.

Report highlights include:

- Exclusive interviews from four companies (Oraya Therapeutics, VisionCare Ophthalmic Technologies, Omeros, and Kala Pharmaceuticals) providing details of their products.

- Both invasive and noninvasive procedures are discussed, along with current treatment options and how they relate to rising therapies.

- Demographic survey and analysis of researchers working in ocular disorders including promising therapeutic options, targets of interest, and challenges encountered.

- Over 250 companies featuring clinical trials and pipeline data.

- Over 200 company and institution profiles included

Key Topics Covered:

Executive Summary

CHAPTER 1: Age-Related Macular Degeneration

CHAPTER 2: Therapeutic Efficacy

CHAPTER 3: Oraya Therapeutics

CHAPTER 4: VisionCare Ophthalmic Technologies

CHAPTER 5: Omeros

CHAPTER 6: Kala Pharmaceuticals

CHAPTER 7: Platforms and Products

CHAPTER 8: Survey of Ocular Industry

CHAPTER 9: Clinical Trials and Pipeline Data

Company Profiles - Partial List

- 13therapeutics, Inc.

- 2C Tech Corporation, Inc.

- AbbVie Inc.

- Abdi Ìbrahim Ìlac Sanayi ve Tic A.S. (Abdi Ibrahim)

- AC Immune SA

- ACADIA Pharmaceuticals

- Aciex Therapeutics, Inc.

- Aciont Inc.

- Acorn Biomedical, Inc.

- Actavis hf.

- Acucela Inc.

- Adamed Sp. z o.o.

- Adenovir Pharma AB

- AdeTherapeutics Inc.

- Alcon Laboratories, Inc.

- Alexion Pharmaceuticals, Inc. Translational Medicine Center

- Alimera Sciences, Inc.

- Alkeus Pharmaceuticals, Inc.

- Allegro Ophthalmics LLC

- Allergan, Inc.

- Allergan S.A.U.

- Altacor

- Altheos, Inc.

- Amakem Therapeutics NV

- AmorChem L.P.

- AngioLab, Inc.

- Ångstrom Pharmaceuticals, Inc.

- Apellis Pharmaceuticals, Inc.

- Apitope International NV

- Applied Genetic Technologies Corp. (AGTC)

- ArcticDx, Inc.

- Argos Therapeutics, Inc.

- AriBio

- Ascendis Pharma A/S

For more information visit http://www.researchandmarkets.com/research/2qx6vb/ocular_disorders

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Optical

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Optical